Hochberg Elaine 4
4 · AKCEA THERAPEUTICS, INC. · Filed Oct 13, 2020
Insider Transaction Report
Form 4
Hochberg Elaine
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2020-10-12$2.01/sh−26,400$53,064→ 0 totalExercise: $16.14Exp: 2030-04-12→ Common Stock (26,400 underlying) - Disposition to Issuer
Stock Option (right to buy)
2020-10-12$5.94/sh−52,837$313,852→ 0 totalExercise: $12.21Exp: 2027-06-04→ Common Stock (52,837 underlying)
Footnotes (2)
- [F1]This option, which provided that 25% of the shares would vest in equal yearly installments over four years on the anniversary of March 13, 2017, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $313,851.78, representing the difference between the exercise price of the option and the acquisition price of $18.15.
- [F2]This option, which provided for vesting of the shares on April 13, 2021, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $53,064.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.